Search

everythinglearnresearchcommunity

for

Search:↓

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

Newer contraceptives with less androgenic progestins may reduce female hair loss.

Platelets and their derivatives, like PRP, can help tissue regeneration, but need standardized safety protocols.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Allopregnanolone may help reduce inflammation and symptoms related to post-finasteride syndrome.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Not enough evidence to support using platelet rich plasma for hair loss treatment.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Platelet-rich plasma improves bladder function and reduces overactivity in ketamine-induced bladder issues.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Both treatments improved hair quality and thickness equally, with mild side effects.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

PRP injections improved facial aesthetics in most women, but more research is needed.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

PRP injections improve hair thickness for baldness.

PRP therapy is promising for hair loss but needs standardized methods and personalization.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Finasteride increases P-glycoprotein activity in the liver and kidney.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

The document is about planning a review to assess if PRP alone is effective for treating hair loss in men and women.

PRP injections improve intestinal healing in rabbits with fewer complications than soaking.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.